This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Ascending cholangitis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Acute cholangitis is acute inflammation and infection of the biliary tract (1).

The onset of acute cholangitis requires 2 factors

  • bile stasis due to chronic obstruction,
    • choledocholithiasis causes up to 80% of cases of acute cholangitis (1)
  • bacterial growth in bile

Not all obstructing lesions are followed by biliary infection

  • about 15% of patients with neoplastic obstruction develop cholangitis
  • the likelihood of infection seems greatest when the duct has acquired a resident bacterial population.

Obstruction causes an increase in ductal pressure. The bacteria proliferate and escape into the systemic circulation via the hepatic sinusoids. The manifestations of sepsis may overshadow those of hepato-biliary disease causing acute suppurative cholangitis.

Without prompt diagnosis and treatment, acute cholangitis can lead rapidly to septicaemia, shock and death (1):

  • mortality of patients with acute cholangitis after 2000 is between 2.7–10 %
    • there is evidence that patients aged 80 years or more have a higher mortality than younger patients
    • poorer prognosis is associated with co-morbid disease, such as cirrhosis, malignancy, liver abscesses, hypoalbuminaemia or coagulopathy

Reference:


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.